A model for predicting nosocomial carbapenem-resistant Klebsiella pneumoniae infection

Biomedical Reports

Volumn 5, Issue 4, 2016, Pages 501-505

  Yang, Duo ^a   Xie, Zeqiang ^a   Xin, Xuli ^a   Xue, Wenying ^a   Zhang, Man ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Carbapenem resistance; Klebsiella pneumoniae; Nosocomial infection; Risk factors

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE;

AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INDWELLING URINARY CATHETER; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

EID: 85030791836     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.752     Document Type: Article

References (18)

1. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT and Daikos GL: Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev 25: 682-707, 2012.
2. Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, et al: Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58: 2322-2328, 2014.
3. Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM and Assous MV: Mortality due to blaKPC Klebsiella peumoniae bacteraemia. J Antimicrob Chemother 71: 1083-1087, 2016.
4. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM and Doi Y: Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56: 2108-2113, 2012.
5. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G and Michalopoulos A: Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: A matched case control study. J Antimicrob Chemother 60: 1124-1130, 2007.
6. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A and Carmeli Y: Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52: 1028-1033, 2008.
7. Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, Losito AR, Tedeschi S, Saffioti C, Corcione S, et al: Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 58: 3514-3520, 2014.
8. Zarkotou O, Pournaras S, Voulgari E, Chrysos G, Prekates A, Voutsinas D, Themeli-Digalaki K and Tsakris A: Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: A matched case-control study. J Clin Microbiol 48: 2271-2274, 2010.
9. Horan TC, Andrus M and Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36: 309-332, 2008.
10. Clinical and Laboratory Standards Institute (CLSI): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard M100. CLSI, Wayne, PA, 2012.
11. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, et al: Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168: 1897-1902, 2008.
12. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, et al: A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176: S1-S44, 2007.
13. Trecarichi EM, Cauda R and Tumbarello M: Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol 7: 1173-1189, 2012.
14. Lucena A, Dalla Costa LM, Nogueira KS, Matos AP, Gales AC, Paganini MC, Castro ME and Raboni SM: Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: Molecular epidemiology, risk factors, clinical features and outcomes. J Hosp Infect 87: 234-240, 2014.
15. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, Trick WE, Weinstein RA and Hayden MK; Centers for Disease Control and Prevention Epicenters Program: The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 57: 1246-1252, 2013.
16. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED and Filos KS: Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67: 2976-2981, 2012.
17. Papadimitriou-Olivgeris M, Christofidou M, Fligou F, Bartzavali C, Vrettos T, Filos KS, Marangos M and Anastassiou ED: The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 42: 883-890, 2014.
18. Bonten MJ: Colonization pressure: A critical parameter in the epidemiology of antibiotic-resistant bacteria. Crit Care 16: 142, 2012.